Driving impairment
This medicine may affect your ability to drive or use machines.
Leaflet QSIVA 7.5mg / 46mg modified-release capsules
- Product code:
- W70853001
- Quantity:
- 14
- Indicated for:
- weight management
- Route of administration:
- oral
- Substance:
- phentermine + topiramate (anti-obesity agent + antiepileptic)
- ATC
- A08AA51 — Alimentary tract and metabolism | Antiobesity preparations, excl. diet products | Centrally acting antiobesity products
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Dizziness / vertigo
This medicine may cause dizziness or vertigo.
Glaucoma warning
Use caution if you have glaucoma or increased eye pressure.
Contraception required
Effective contraception is required during treatment.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Suicidal ideation / mental changes
Seek medical help if suicidal thoughts or major behavior changes occur.
Teratogenic / fetal risk
This medicine may affect fetal development.
Drowsiness / sedation
This medicine may cause drowsiness or reduced alertness.
Vision disturbances
This medicine may cause vision disturbances.
The combination of phentermine and topiramate is used for the management of obesity in patients who have not succeeded in losing weight through diet and exercise. Phentermine is an appetite suppressant, while topiramate helps reduce cravings and increase feelings of fullness.
The medication is taken orally, usually once daily, and should be used as directed by your doctor. It is important to combine the treatment with a healthy lifestyle to achieve the best results.
Side effects may include insomnia, dizziness, dry mouth, constipation, or, in rare cases, psychiatric or cardiovascular disorders.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as hypertension or kidney diseases, to ensure the safe use of this combination.
The medication is taken orally, usually once daily, and should be used as directed by your doctor. It is important to combine the treatment with a healthy lifestyle to achieve the best results.
Side effects may include insomnia, dizziness, dry mouth, constipation, or, in rare cases, psychiatric or cardiovascular disorders.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as hypertension or kidney diseases, to ensure the safe use of this combination.
General data about QSIVA 7.5mg / 46mg
- Substance:
- phentermine + topiramate
- Date of latest medicines list:
- 01-02-2025
- Product code:
- W70853001
- Concentration:
- 7.5mg / 46mg
- Pharmaceutical form:
- modified-release capsules
- Quantity:
- 14
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for phentermine + topiramate
- 11.25mg/69mg
- 15mg/92mg
- 3.75mg/23mg
- 7.5mg/46mg